GLP-1 patients who don’t respond stayed on therapy anyway, study finds
A 12.7 million-patient analysis finds less effective GLP-1 users with Type 2 diabetes persisted on therapy at nearly the same rate as effective users, with no improvement in blood sugar or weight
Read more: https://www.insurancebusinessmag.com/us/news/benef...
Scan with your phone
Scan with your phone